KidsOncDoc Profile Banner
Dr. Tim Cripe, M.D. Ph.D Profile
Dr. Tim Cripe, M.D. Ph.D

@KidsOncDoc

Followers
803
Following
973
Media
214
Statuses
701

Physician-scientist @nationwidekids. Host of This Week in Peds Oncology, the podcast about #kidscancer #childhoodcancer #immunotherapy #genetherapy #oncolytic

Columbus, OH
Joined June 2011
Don't wanna be here? Send us removal request.
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
8 months
Imagine if there was a legal performance enhancing drug that makes you strong enough to resist getting sick from an infection? Even better, you only take it once and you are stronger for life! #vaccinessavelives #preventionisthebestmedicine #legalPED
0
0
2
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
9 months
0
0
7
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
What a compelling essay. Thank you Craig for being will to share your personal story.
@CancerConnector
Jake Scott
1 year
Great story on our new @vironexis programmable #genetherapy platform to create lifelong t-cell engaging bispecific antibodies from a single infusion - from @Medium @OncoAlert @oncodaily @MedscapeOnc @nationwidekids https://t.co/RXVkYcsh9D
0
1
3
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
Congrats to our collaborative group enabled by the @theNCI PI-DDN.
@jitcancer
Journal for ImmunoTherapy of Cancer
1 year
New #JITC article: Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy https://t.co/oV70dWi477 @KidsOncDoc
0
0
2
@vironexis
Vironexis Biotherapeutics
1 year
Great article by Elizabeth Eaton in @fwpharma about our platform technology, pipeline and mission to transform cancer treatment for patients with AAV-delivered T-cell immunotherapy! See article: https://t.co/DeJCZVZcJQ
1
2
3
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
Thank you @nationwidekids and @vironexis and especially my outstanding laboratory team at NCH including Mark Currier, Brian Hutzen, Pin-Yi Wang, Chun-Yu Chen, & Andrea Glaspell for making great progress so far!
vironexis.com
We aim to revolutionize the immunotherapy landscape and transform the treatment of cancer.
1
0
4
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
Congrats to Dr Paudel for publishing his PhD thesis work from our lab in Frontiers | Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors #MPNST #NF1 #TVEC
Tweet card summary image
frontiersin.org
IntroductionMalignant peripheral nerve sheath tumors (MPNST) pose a significant therapeutic challenge due to high recurrence rates after surgical resection a...
0
0
6
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
Congrats to all graduating ⁦@nationwidekids⁩ hematology/oncology/BMT fellows, especially our 4th year sarcoma fellow Dr Alejandra Rosales, shown here with the sarcoma team doctors. They are lucky to get you ⁦@LSUHealthNO⁩ in Shreveport as a new Assistant Professor!
0
0
8
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
We still need books
0
0
6
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
Thanks to @nationwidekids Dr Kevin Cassady for leading this study showing IL12 gene therapy improves oncolytic viroimmunotherapy in preclinical models of #MPNST #sarcoma
Tweet card summary image
frontiersin.org
IntroductionMalignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with unacceptably low cure rates occurring often in patients with neuro...
0
3
18
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
Congrats to @nationwidekids Dr Mark Ranalli shown here presenting interim results at #ASCO24 of his clinical trial using adoptive NK cells for pediatric patients with #neuroblastoma (STING) being run through NANT based on our NCH colleague Dr Dean Lee’s work
0
0
18
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
1 year
Thanks to #childhoodcancer research luminaries Drs Jim Armatruda, Brenda Weigel, and Mark Hatley for being external advisors to our ⁦@nationwidekids@theNCI⁩ funded T32 training program and thanks to our trainees for giving inspiring research talks today! #cancerlauNCH
0
2
20
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
2 years
We are pleased to have ⁦@NeuroOncDoc⁩ delivering our @nationwidekids #childhoodcancer T32 lecture today on the #glioma microenvironment and how he hopes to prevent malignant transformation of low grade to high grade
0
0
11
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
2 years
Reviving the lost art of meeting reports - ScienceDirect
0
1
1
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
2 years
Progress in sarcomas: Highlights from the 2023 annual meetingof the Co...
0
2
3
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
2 years
@OhioState⁩ About to give a graduate lecture at The Ohio State University without a virtual option - talk about old school! I hope students show up….! #oldfashioned #vintage #inpersonrocks
0
0
25
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
2 years
It’s a fantastic day for our patients! Thank you for the partnership @OSUCCC
@OSUCCC_James
The James at Ohio State
2 years
It's a great day for #cancer care in Columbus, where we've cut the ribbon on our proton therapy center at The James Outpatient Care. The state-of-the-art center brings effective, precision proton therapy to adult and pediatric cancer patients from The James and @nationwidekids.
0
3
11
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
2 years
.⁦@nationwidekids⁩ welcomes ⁦⁦@BuckeyeThon⁩ tonight!
0
0
8
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
2 years
Congrats to @OhioState Molecular Cellular Developmental Biology PhD candidate Emily Franz comentored by me @nationwidekids and Dr Ryan Roberts @KidCancerLab for her poster award at the international sarcoma mtg in Dublin Ireland #CTOS hopefully she will be submitting paper soon!
0
2
8
@KidsOncDoc
Dr. Tim Cripe, M.D. Ph.D
2 years
Great to see Jack Shern ⁦@theNCI⁩ highlight the ⁦@COGorg⁩ partnership on the #childhoodcancer Molecular Characterization Initiative and the genomic work done ⁦@nationwidekids⁩⁩ at the international sarcoma meeting in Dublin #CTOS2023
0
0
5